vimarsana.com

Page 52 - அமைச்சகம் ஆஃப் ஆரோக்கியம் குடும்பம் நலன்புரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Super speciality hospital to start soon in Anantapur

Super speciality hospital to start soon in Anantapur Updated Jan 3, 2021, 11:11 am IST The well-equipped hospital will ensure that people of the area will not have to approach corporate hospitals in Bengaluru and Hyderabad  Anantapur Urban MLA Ananta Venkatrami Reddy hoped the super specialty hospital will soon start providing quality of medical services to people of Anantapur district. (File photo) Anantapur: The super specialty hospital at Anantapur, being set up as part of post-bifurcation package, will soon start providing services to people of Anantapur as also those from the surrounding districts of Rayalaseema. The well-equipped hospital will ensure that people of the area will not have to approach corporate hospitals in Bengaluru and Hyderabad for different specialised treatments.

Covaxin s emergency use authorisation approval significant landmark in India s scientific discovery

Updated Jan 03, 2021 | 13:41 IST Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses. Representational Image  Hyderabad: Expressing delight on the Ministry of Health & Family Welfare announcement and the statement from DCGI - Central Standards Control Organization (CDSCO) Grant of permission for emergency use of its Covid-19 Vaccine today, the Chairman and Managing Director of Bharat Biotech Dr Krishna Ella said “The approval of COVAXIN™ for emergency use is a giant leap for Innovation and novel product development in India. It is a proud moment for the nation and a great milestone in India’s scientific capability, a kickstart to the innovation ecosystem in India. While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the mo

Govt to bear vaccination cost of 30 crore people from priority group, says Covid task force head

Dr Vinod Paul, Niti Aayog member and the national Covid task force head, has said the government will cover the vaccination cost of 30 crore people from the priority group in phase 1 of the vaccination drive.

India s Corona curve rises to 1,02,07,871 with 20,021 new cases

India s Corona curve rises to 1,02,07,871 with 20,021 new cases India on Monday logged 20,021 fresh Covid-19 infections taking the total number of cases to 1,02,07,871, along with   |  29 Dec 2020 4:03 AM GMT NEW DELHI: India on Monday logged 20,021 fresh Covid-19 infections taking the total number of cases to 1,02,07,871, along with 279 deaths in the last 24 hours, taking the tally of fatalities to 1,47,901. In the last 24 hours, 21,131 people have recovered, taking the total number of the recovered people to 97,82,669. There are 2,77,301 active cases. The recovery rate stands at 95.83 per cent while the fatality rate is 1.45 as per cent, said the Ministry of Health & Family Welfare. A total of 16,88,18,054 samples have been tested for COVID-19 till now. Of these, 7,15,397 samples were tested on Sunday, said the Indian Council of Medical Research (ICMR).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.